Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
Lupus - Investigators at College of Medicine, Division of Rheumatology target lupus
Non-Hodgkin Lymphoma Therapy - Reports outline non-hodgkin lymphoma therapy study findings from University Hospital, Department of Internal Medicine I
Alcoholism - Study results from S. Nakano and colleagues in the area of alcoholism published
Hepatitis - Investigators at Niigata University target hepatitis
Hepatitis - Recent findings in hepatitis described by researchers from University of Otago
Hepatitis - Recent findings in hepatitis described by S. Mochida and colleagues
Hepatitis - Research from W. Gao and co-researchers provides new data on hepatitis
Hepatitis - Research on hepatitis described by K. Su and colleagues
Hepatitis - Scientists at University of Tokyo, Medical Department publish new data on hepatitis
Hepatocellular Cancer - Research findings from Marshall University, Medical Department update understanding of hepatocellular cancer
Transplantation - Studies from Niigata University have provided new data on transplantation
Clinical Trial Research - Tigermed Forms Strategic Partnerships With Leading CROs in Russia and South Korea
HIV/AIDS Co-Infection - Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals' Bavituximab to Cure Lethal Virus Infections
Life Sciences - Cybit wins first major UK order for Fleetstar Logistics
Life Sciences - gMeds New gGastro EMR an Ease-of-Use Breakthrough
Schering-Plough Corporation - Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C